Sigilon Therapeutics Inc (SGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,859 | -77,311 | -59,566 | -39,410 | -18,973 |
| Depreciation Amortization | 351 | 1,121 | 816 | 510 | 247 |
| Accounts receivable | -3 | 118 | 150 | -1 | 37 |
| Accounts payable and accrued liabilities | -186 | 713 | 1,560 | 3,046 | 578 |
| Other Working Capital | -8,867 | -13,420 | -11,235 | -5,951 | -6,915 |
| Other Operating Activity | 3,076 | 10,374 | 7,249 | 3,146 | 2,353 |
| Operating Cash Flow | $-19,488 | $-78,405 | $-61,026 | $-38,660 | $-22,673 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -397 | -1,834 | -1,532 | -997 | -290 |
| Purchase Of Investment | -22,819 | -16,226 | 0 | N/A | N/A |
| Investing Cash Flow | $-23,216 | $-18,060 | $-1,532 | $-997 | $-290 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 48 | 2,176 | 1,519 | N/A | N/A |
| Other Financing Activity | 0 | -622 | -622 | 9 | -477 |
| Financing Cash Flow | $48 | $1,554 | $897 | $9 | $-477 |
| Beginning Cash Position | 203,422 | 203,422 | 203,422 | 203,422 | 203,422 |
| End Cash Position | 160,766 | 108,511 | 141,761 | 163,774 | 179,982 |
| Net Cash Flow | $-42,656 | $-94,911 | $-61,661 | $-39,648 | $-23,440 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,488 | -78,405 | -61,026 | -38,660 | -22,673 |
| Capital Expenditure | -397 | -1,834 | -1,532 | -997 | -290 |
| Free Cash Flow | -19,885 | -80,239 | -62,558 | -39,657 | -22,963 |